NEW: Find great deals on the latest gadgets and more in the ScienceDaily Store!
Science Videos
from news services

Pfizer Needs AstraZeneca More Than Ever as Generics Increase

May 5, 2014
TheStreet / Powered by
Pfizer shares are slipping after the drug maker posted first-quarter profits 15% lower than a year earlier and revenue down 9%. Net income of 57 cents a share beat expectations by 2 cents, but $11.3 billion in sales fell short of analysts' estimates of $12.1 billion. The weaker-than-expected report comes days after its latest offer to purchase British drug maker AstraZeneca for $106 billion was rejected. Pfizer has seen lost profits on greater competition from generic brands on the market. Video provided by TheStreet
Related Videos

Share This Page:

Health & Medicine News
October 28, 2016

Latest Headlines
updated 12:56 pm ET